SHS Gesellschaft für Beteiligungsmanagement mbH
29. April 2021 - Newsletter, Portfolio News

Novel GFRNMR test from numares guarantees more precise testing of kidney function

numares AG, a leader in NMR metabolomics-based diagnostics, has developed a novel multi-marker approach – GFRNMR – to determine kidney function using simple serum tests. The combination of multiple renal biomarkers can exceed the diagnostic limitations of the established method for estimating GFR (glomerular filtration rate). The assessment of kidney function is extremely important for millions of people with chronic kidney disease, affecting approximately 37 million people in the US alone. numares AG has installed the new test as an LDT at two customers in the USA. An NMR system was also handed over and installed in a laboratory in Texas.

You can find more information here: